Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma
利用氟苯达唑抑制PCSK9依赖性活性来抑制肿瘤发生并增强乐伐替尼治疗肝细胞癌的疗效
期刊:International Journal of Biological Sciences
影响因子:8.2
doi:10.7150/ijbs.81415
Wenjiao Jin,Junming Yu,Yang Su,Hechun Lin,Tengfei Liu,Jing Chen,Chao Ge,Fangyu Zhao,Qin Geng,Lin Mao,Shuqing Jiang,Ying Cui,Taoyang Chen,Guoping Jiang,Jinjun Li,Chunxiao Miao,Xiuying Xiao,Hong Li